Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Medicare Making Changes to Improve Behavioral Health Care Access

Client Alert

The Centers for Medicare & Medicaid Services (CMS) recently announced changes to Medicare beneficiaries’ ability to access behavioral health care.

Currently, Medicare covers psychiatric hospitalization for people with acute psychiatric needs, partial hospitalization program services, and outpatient mental health treatment and therapy services. As mental health diagnoses for Medicare-eligible Americans increase, there has been a notable gap in coverage for certain services and certain providers.

In response, Medicare has implemented the following changes:

  1. Permitting Marriage and Family Therapists and Mental Health Counselors (including alcohol and drug counselors who meet the Mental Health Counselor requirements) to independently enroll in Medicare. To date, these providers could not independently enroll as Medicare providers.
  2. Paying for Community Health Integration and Principal Illness Navigation services. Notably, CMS is permitting these services to be provided by community health workers and peer support specialists. These services are especially important for beneficiaries whose social needs (i.e., food, housing, and transportation) interfere with their receipt of health care.
  3. Changing the required level of supervision for behavioral health services performed at federally qualified health centers (FQHCs) and rural health clinics (RHCs). Now, certain behavioral health services at FQHCs and RHCs can be provided with “general” supervision instead of “direct” supervision. Practically, this means that behavioral health providers can now provide certain vital services without a doctor or advanced practice practitioner physically present on-site.
  4. Increasing reimbursement for crisis psychotherapy services to 150% of the usual Physician Fee Schedule rate when crisis care is provided outside of health care settings (i.e., in the community).
  5. Increasing reimbursement for substance use disorder treatment provided in an office setting to better reflect the actual costs of the services.

These changes are part of the 2024 Physician Fee Schedule Final Rule, 2024 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems Final Rule, and 2025 Proposed Medicare Advantage and Part D rules.

If you have questions about expanded Medicare coverage and what that means for your patients or organization, or Medicare coverage of behavioral health services, please contact Member Daphne Kackloudis at dlkackloudis@bmdllc.com or Associate Jordan Burdick at jaburdick@bmdllc.com.


Effective December 12, 2024: Key Updates to Ohio Medicaid Rules for CPC and CMC Programs

Ohio Medicaid has amended rules for the Comprehensive Primary Care (CPC) and Comprehensive Maternal Care (CMC) programs, effective December 12, 2024. Key updates include expanded provider eligibility, stricter cultural competency training timelines, new clinical quality metrics, and changes to maternal care requirements.

Ohio Medicaid Extends Timely Filing Deadline Until 2025

The Ohio Department of Medicaid (ODM) recently announced that it is extending its timely filing deadline to February 28, 2025. According to ODM, roughly 2% of providers have contract issues preventing them from meeting the previous timely filing deadline of December 1, 2024.

Another Drug Manufacturer Pursues Rebate Program as 340B Alternative

Some of the nation’s largest drug manufacturers are forging ahead to implement rebate programs for 340B drugs, even after the federal government has called these programs illegal. While it is unclear how these federal courts will rule, this could threaten the sustainability of safety net providers and their patients.

Hurry Up, STOP. . .Has CTA Been Struck Down By Courts?

Following a recent case in Texas, uncertainty has arisen regarding whether clients should file "beneficial owners" reports. This is a result of the Federal Government enjoined from enforcing the CTA. Contact your BMD Member Blake Gerney to find out how this affects you.

DEA and HHS Issue its Third Extension of Telemedicine Flexibilities through 2025

The DEA and U.S. Department of Health and Human Services (HHS) have extended telemedicine flexibilities for prescribing controlled medications through December 31, 2025. This extension builds on temporary exceptions made in 2020 due to COVID-19, allowing providers to prescribe Schedule II-V controlled substances based on a telemedicine evaluation alone. The extension ensures continued patient access to necessary prescriptions and provides time for providers to comply with future regulations.